Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate

Background. In non-dialysis chronic kidney disease (CKD), absolute proteinuria (Uprot) depends on the extent of kidney damage and residual glomerular filtration rate (GFR). We therefore evaluated, as compared with Uprot, the strength of association of proteinuria indexed to estimated GFR (eGFR

[1]  Sue-Kyung Park,et al.  Hepcidin, iron indices and bone mineral metabolism in non-dialysis chronic kidney disease. , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  M. Karsdal,et al.  Urinary endotrophin predicts disease progression in patients with chronic kidney disease , 2017, Scientific Reports.

[3]  Miles A. Miller,et al.  Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates , 2017, Journal of Cancer.

[4]  Beata Franczyk,et al.  Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome , 2017, International journal of molecular sciences.

[5]  J. Coresh,et al.  Update on the Burden of CKD. , 2017, Journal of the American Society of Nephrology : JASN.

[6]  D. Santoro,et al.  Epidemiology of low-proteinuric chronic kidney disease in renal clinics , 2017, PloS one.

[7]  R. Minutolo,et al.  Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question , 2016, Journal of Nephrology.

[8]  J. Pascual,et al.  RAS and sex differences in diabetic nephropathy. , 2016, American journal of physiology. Renal physiology.

[9]  F. Kronenberg,et al.  Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. , 2016, JAMA.

[10]  F. Locatelli,et al.  Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[11]  J. Hoekman,et al.  Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis. , 2015, Journal of the American Society of Nephrology : JASN.

[12]  M. Woodward,et al.  Kidney measures beyond traditional risk factors for cardiovascular prediction: A collaborative meta-analysis , 2015, The lancet. Diabetes & endocrinology.

[13]  R. Minutolo,et al.  Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care , 2015, PloS one.

[14]  Olga V. Demler,et al.  Tests of calibration and goodness‐of‐fit in the survival setting , 2015, Statistics in medicine.

[15]  B. Astor,et al.  Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK). , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  F. Lapi,et al.  Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[17]  C. Parikh,et al.  Key concepts and limitations of statistical methods for evaluating biomarkers of kidney disease. , 2014, Journal of the American Society of Nephrology : JASN.

[18]  B. Astor,et al.  Relative risks of Chronic Kidney Disease for mortality and End Stage Renal Disease across races is similar , 2014, Kidney international.

[19]  Eric Thervet,et al.  Renal Function Can Improve at Any Stage of Chronic Kidney Disease , 2013, PloS one.

[20]  F. Locatelli,et al.  Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  Josef Coresh,et al.  Cystatin C versus creatinine in determining risk based on kidney function. , 2013, The New England journal of medicine.

[22]  J. Fine,et al.  A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. , 2013, Journal of clinical epidemiology.

[23]  H. Mischak,et al.  CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis , 2013, PloS one.

[24]  C. Zoccali,et al.  The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. , 2012, Kidney international.

[25]  G. Remuzzi,et al.  Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes , 2012, Diabetes Care.

[26]  H. Mischak,et al.  Urinary proteomics in the assessment of chronic kidney disease , 2011, Current opinion in nephrology and hypertension.

[27]  C. Zoccali,et al.  Prognosis of CKD patients receiving outpatient nephrology care in Italy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[28]  H. Uno,et al.  Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation. , 2011, American heart journal.

[29]  Mark Woodward,et al.  Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. , 2011, Kidney international.

[30]  Giuseppe Conte,et al.  Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. , 2011, Archives of internal medicine.

[31]  Laura E. Clark,et al.  Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. , 2011, Kidney international.

[32]  J. Wetzels,et al.  Estimated glomerular filtration rate in the nephrotic syndrome. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[34]  M. El Nahas,et al.  Proteinuria Thresholds Are Irrational: A Call for Proteinuria Indexing , 2010, Nephron Clinical Practice.

[35]  Michael J. Pencina,et al.  Statistical methods for assessment of added usefulness of new biomarkers , 2010, Clinical chemistry and laboratory medicine.

[36]  H. Rakugi,et al.  Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[37]  M. Tokumoto,et al.  Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  P. Ravani,et al.  Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  Nancy R Cook,et al.  Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures , 2009, Annals of Internal Medicine.

[40]  A. Webster,et al.  Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  R. Agarwal.  Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[42]  Alicja R. Rudnicka,et al.  Measures to assess the prognostic ability of the stratified Cox proportional hazards model , 2009, Statistics in medicine.

[43]  Elizabeth Selvin,et al.  Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study. , 2008, Archives of internal medicine.

[44]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[45]  O. Pedersen,et al.  Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. , 2006, Diabetes care.

[46]  P. Zamboli,et al.  Management of hypertension in patients with CKD: differences between primary and tertiary care settings. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  J. Daurès,et al.  Regression splines for threshold selection in survival data analysis. , 2001, Statistics in medicine.

[48]  H. Boshuizen,et al.  Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.

[49]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[50]  H. Akaike.  A new look at the statistical model identification , 1974 .

[51]  Miles A. Miller,et al.  Simultaneous Detection of Metalloprotease Activities in Complex Biological Samples Using the PrAMA (Proteolytic Activity Matrix Assay) Method. , 2017, Methods in molecular biology.

[52]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[53]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .